RareMD

RareMD Inc. is a digital health company dedicated to shortening the "diagnostic odyssey" for patients with rare diseases. Founded in 2016 by former Genzyme executive Dick Meijer, the company provides AI-enhanced differential diagnosis tools that analyze clinical phenotypes and biomarkers. Its primary platforms include RareMDx™, designed for medical professionals to generate ranked lists of potential rare disease diagnoses, and RareLook™, a patient-facing version that empowers caregivers and families to participate in the diagnostic process. The company's database covers over 4,100 rare diseases and 7,600 clinical phenotypes, aiming to provide timely and accurate diagnostic support globally.